Carl Zeiss Meditec AG

M&A Activity • Dec 17, 2004

News Details

Ad-hoc | 17 December 2004 07:20

Carl Zeiss Meditec acquires majority holding in IOLTECH

Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– Carl Zeiss Meditec acquires majority holding in IOLTECH —Expanded position in market for ophthalmic surgery – Combination of systems and implants opens up further growth potential— (Jena, Germany / La Rochelle, France, 17 December 2004) The medical solutions provider, listed in the Prime Standard at the Deutsche Börse, will take over about 63 percent of the shares in the ophthalmic surgery specialist IOLTECH. This company, listed on the Second Marché at the Paris Stock Exchange, specialises in the production and distribution of intra-ocular lenses (IOL). IOLTECH sales for the last financial year amounted to EUR 44.7 million. The price offered to the majority shareholder values 100 percent of IOLTECH’s shares at EUR 110 million, which represents EUR 91.80 per IOLTECH share and corresponds to a premium of 15.6 percent on the IOLTECH average weighted share price of the last three months. Carl Zeiss Meditec will pay for 80 percent of the bloc shares in cash and for 20 percent by issuing new Carl Zeiss Meditec AG shares. These terms are the subject of an agreement signed by the majority shareholder of IOLTECH and Carl Zeiss Meditec AG on in the night between 16 and 17 December 2004. The transaction is still among other things subject to the approval of the German anti-trust authority. Subsequent to getting all these approvals the bloc acquisition should be finalised by mid of February 2005. After acquiring the majority of the shares, Carl Zeiss Meditec AG is aiming at a complete takeover of IOLTECH. Accordingly, in a second step Carl Zeiss Meditec will submit a take-over bid at the same amount of EUR 91.80 per share in cash to the remaining shareholders of IOLTECH. Contact Carl Zeiss Meditec AG: Jens Brajer/Director Investor Relations, Phone: +49 (0)3641-220-105, Fax: +49 (0)3641-220-117, E-mail: investors@meditec.zeiss.com Contact IOLTECH SA Annabelle Bretaudeau, Phone: +33-546 44 85 50 end of ad-hoc-announcement (c)DGAP 17.12.2004 ——————————————————————————– WKN: 531370; ISIN: DE0005313704; Index: Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart 170720 Dez 04